Who We Are Who We Serve Solutions Blog SEARCH
Contact Us
Who We AreWho We ServeSolutionsBlog
Our Leadership Our Consultants Join Our Team Latest News
Pharmacy Benefit Consulting Data & Analytics
EmployersHealth PlansHospitalsLabor Unions
LibrarySpeakers BureauNews

News

06/08/2022
Employers and Labor Unions, Integrated Data, News, PBM, Specialty Drugs
Trends in Specialty Drug Benefit Design: New to market formulary blocks
06/07/2022
Employers and Labor Unions, Health Payers, Integrated Data, News, PBM, Prior Authorizations, Specialty Drugs
Trends in Specialty Drug Benefit Design: Member Engagement
06/06/2022
Employers and Labor Unions, Integrated Data, News, PBM, Specialty Drugs
Trends in Specialty Drug Benefit Design: Rebates

05/10/2022
Health Payers, News
2023 Medicare Advantage and Part D Final Rule on Pharmacy Price Concessions
10/08/2021
Biosimilars, Employers and Labor Unions, FDA, Formulary, Health Payers, Hospitals & Health Systems, News, PBM, Specialty Drugs
Insights into CVS 2022 Formulary Changes
08/26/2021
Employers and Labor Unions, Formulary, Health Payers, Integrated Data, News, PBM, Specialty Drugs
Insights into Express Scripts 2022 NPF and Flex Formulary Changes

07/09/2021
FDA, Health Payers, News, Prior Authorizations
UPDATED: Key Insights on New Alzheimer’s Drug
06/24/2021
FDA, Health Payers, Integrated Data, News, PBM, Prior Authorizations
PSG Insights: New Weight Loss Drug – Wegovy
04/28/2021
Employers and Labor Unions, Formulary, Health Payers, News, PBM, Specialty Drugs
Upcoming 2021 Midyear Express Scripts Formulary Changes

04/21/2021
COVID-19 News and Updates, Diabetes, Health Payers, News, PBM, Specialty Drugs
Ten Takeaways from the Evernorth Drug Trend Report
01/13/2021
COVID-19 News and Updates, Employers and Labor Unions, FDA, News
COVID-19 Vaccine Questions Answered
12/11/2020
COVID-19 News and Updates, Employers and Labor Unions, FDA, Health Payers, Let's Talk, News, Specialty Drugs
Let’s Talk COVID-19 Vaccines

11/30/2020
Employers and Labor Unions, Formulary, Health Payers, News
PSG Position: President Trump’s Latest Executive Order
10/14/2020
Biosimilars, Diabetes, Employers and Labor Unions, FDA, Formulary, Health Payers, News, PBM, Specialty Drugs
Insights into the 2021 PBM Formulary Changes
10/02/2020
Employers and Labor Unions, Formulary, Health Payers, News, PBM, Specialty Drugs
Upcoming 2021 CVS Formulary Changes

09/21/2020
Employers and Labor Unions, Formulary, Health Payers, News, PBM, Specialty Drugs
Upcoming 2021 OptumRx Formulary Changes
09/15/2020
Employers and Labor Unions, Health Payers, News
President Trump’s Executive Order on Lowering Drug Prices
08/19/2020
FDA, Gene Therapy, Health Payers, News
FDA delayed approval of gene therapy drug, Roctavian

PSG is the leading pharmacy intelligence and technology company solving one of healthcare’s biggest challenges – rising drug costs. We provide innovative drug management solutions to over 300 clients who rely on our team of trusted advisors to improve their financial performance.
Who We Are Who We Serve Solutions Resources Blog Join our Team Contact Privacy Policy
PHARMACEUTICAL STRATEGIES GROUP
14881 Quorum Drive, Suite 850
Dallas, TX 75254 | 800.687.4404
SERVICE DESK 844-PSG-340B